161
Views
3
CrossRef citations to date
0
Altmetric
Original

Messages and findings from the Department of Health drugs misuse research initiative: final overview report

Pages 1-136 | Published online: 10 Jul 2009

References

  • Acheson D. Independent inquiry into inequalities in health. Stationery Office, London 1998
  • Advisory Council on the Misuse of Drugs. Drug misuse and the environment. Stationery Office, London 1998
  • Advisory Council on the Misuse of Drugs. Hidden harm: Responding to the needs of problem drug users. Home Office, London 2003
  • Audit Commission. Misspent youth: Young people and crime. Audit Commission, London 1996
  • Audit Commission. Changing habits: The commissioning and management of community drug treatment services for adults. Audit Commission, London 2002
  • Aust R, Sharp C, Goulden C. Prevalence of drug use: Key findings from the 2001/2002 British Crime Survey, Findings 182. Home Office Research, Development and Statistics Directorate, London 2002
  • Banerjee S, Clancy C, Crome I. Coexisting problems of mental disorder and substance misuse (dual diagnosis): An information manual. Royal College of Psychiatrists College Research Unit, London 2001
  • Coggans N, Dalgarno P, Johnson L, Shewan D. Long-term heavy cannabis use: Executive summary. 2002a
  • Coggans N, Dalgarno P, Johnson L, Shewan D. Long-term heavy cannabis use. Final Report to the Department of Health. 2002b, 153
  • Crawforn V, Crome I. Coexisting problems of mental health and substance abuse (dual diagnosis): A review of the relevant literature. London 2001, Report to the Department of Health/Royal College of Psychiatrists College Research Unit
  • Department of Health. Task force to review services for drug misusers: Report of an Independent Review of Drug Treatment Services in England. (Chairman: The Reverend Dr. John Polkinghorne). Department of Health, London 1996
  • Department of Health. Our healthier nation: A contract for health. Stationery Office, London 1998a
  • Department of Health. Modernising mental health services. Department of Health, London 1998b
  • Department of Health. Drug misuse and dependence—Guidelines on clinical management. Department of Health, London 1999
  • Department of Health. Statistical bulletin 2001/33: Statistics from the regional drug misuse databases on drug misusers in treatment in England 2000/01. Office for National Statistics, London 2001
  • Department of Health. Mental health policy implementation guide: Dual diagnosis good practice. Department of Health, London 2002
  • Donmall M, Watson A, Millar T, Dunn G. Outcome of Waiting Lists Study (OWL): Waiting for drug treatment—effects on uptake and immediate outcome. Executive summary. 2003a
  • Donmall M, Watson A, Millar T, Dunn G. Outcome of Waiting Lists Study (OWL): Waiting for drug treatment—effects on uptake and immediate outcome. Report to the Department of Health. 2003b, 122
  • Editorial. Dangerous habits. The Lancet 1998; 352: 1565
  • Farrell M. Co-morbidity in the national psychiatric morbidity surveys. Department of Health, London 2004
  • Frisher M, Crome I, Croft P, Millson D, Collins J, Conolly A. A national epidemiological study of co-morbid substance abuse and psychiatric illness in primary care between 1993–1998 using the General Practice Research Database. Final Report to the Department of Health. 2002, 56
  • Frisher M, Collins C, Millson D, Crome I, Croft P. Prevalence of co-morbid psychiatric illness and substance misuse in primary care in England and Wales. Journal of Epidemiology and Community Health 2004; 58: 1036–1041
  • Frisher M, Crome I, Macleod J, Millson D, Croft P. Substance misuse and psychiatric illness: Prospective observational study using the general practice research database. Journal of Epidemiology and Community Health 2005; 59: 847–850
  • Fuller E. Drug use, smoking and drinking among young people in England in 2004. Department of Health, London 2005
  • Godfrey C, Eaton G, McDougall C, Culyer A. The economic and social costs of class A drug use in England and Wales. Home Office Research Study, London 2002
  • Gossop M, Marsden J, Stewart D. NTORS at one year: The National Treatment Outcome Research Study. Changes in substance use, health and criminal behaviours at one year after intake. Department of Health, London 1998
  • Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction 2003; 98: 291–303
  • Hall W. The effects of adolescent cannabis use: How should empirical evidence influence policy?. Paper presented at the JRF Drugs and Alcohol Seminar Series. July, 2005. London School of Hygiene and Tropical Medicine, UK
  • Home Office. Updated Drug Strategy 2002. Home Office Drugs Strategy Directorate, London 2002
  • Hough M. Drugs misuse and the criminal justice system: A review of the literature. DPI Paper 15. Home Office, London 1996
  • Ley A, Jeffery DP, Mclaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). The Cochrane Database of Systematic Reviews 1999, 3
  • MacGregor S. Drugs research funded by Central Government Departments: A review. Report to the Department of Health. 2001
  • Macleod J, Oakes R, Oppenkowski T, Stokes-Lampard H, Copello A, Crome I, et al. The psychosocial consequences of drug misuse: a systematic review of longitudinal studies: Executive Summary. 2002a
  • Macleod J, Oakes R, Oppenkowski T, Stokes-Lampard H, Copello A, Crome I, et al. The psychosocial consequences of drug misuse: a systematic review of longitudinal studies. Report to the Department of Health. 2002b, 191
  • Marsden J, Stillwell G, Barlow H, Taylor C, Boys A, Hunt N. An evaluation of a brief intervention model for use with young non-injecting stimulant users: Executive summary. 2004a
  • Marsden J, Stillwell G, Barlow H, Taylor C, Boys A, Hunt N. An evaluation of a brief intervention model for use with young non-injecting stimulant users. Report to the Department of Health. 2004b, 197
  • McKeganey N, McIntosh J, MacDonald F, Gilvarry E, McHardle P, McCarthy S, et al. Preteens and illegal drugs: Use, offers, exposure and prevention: Executive summary. 2003a
  • McKeganey N, McIntosh J, MacDonald F, Gilvarry E, McHardle P, McCarthy S, et al. Preteens and illegal drugs: Use, offers, exposure and prevention. Report to Department of Health. 2003b, 125
  • Merrill J, McBride A, Pates R, Peters L, Tetlow A, Roberts C, et al. Dexamphetamine substitution as a treatment of amphetamine dependence: A two-centre randomised controlled trial. Executive summary. 2004a
  • Merrill J, McBride A, Pates R, Peters L, Tetlow A, Roberts C, et al. Dexamphetamine substitution as a treatment of amphetamine dependence: A two-centre randomised controlled trial. Final report to the Department of Health. 2004b, 89
  • Metrebian N, Stimson GV, Shanahan W, Alcorn R, Sell L, Nunn A, Gabe R, Knapp M, et al. Pilot UK-Injectable Methadone Trial (Pilot-UK INJECT): Executive summary. 2003a
  • Metrebian N, Stimson GV, Shanahan W, Alcorn R, Sell L, Nunn A, Gabe R, Knapp M, et al. Pilot UK-Injectable Methadone Trial (Pilot-UK INJECT). Final Report to the Department of Health. 2003b, 43pp plus appendices
  • Moring J, Barrowclough C, Haddock J, Hopper M, Roberts C, Telfer I. Accessing drug services: Needs and views of drug service users: Executive summary. 2004a
  • Moring J, Barrowclough C, Haddock J, Hopper M, Roberts C, Telfer I. Accessing drug services: Needs and views of drug service users. Report to Department of Health. March, 2004b, 111
  • National Treatment Agency. Models of care for the treatment of substance misusers: Promoting quality, efficiency and effectiveness in drug misuse treatment services in England. NTA, London 2002a
  • National Treatment Agency. Making the system work. Summary guidance on managing and reducing waiting times for specialist drug treatment services in England. NTA, London 2002b
  • Police Foundation. Drugs and the law: Report of the independent inquiry into the Misuse of Drugs Act 1971 (The Runciman Report). Police Foundation, London 2000
  • Social Exclusion Unit. Reducing re-offending by ex-prisoners. Social Exclusion Unit, London 2002
  • Strang J, Best D, Ridge G, Gossop M, Farrell M. Randomised clinical trial of the effects of time on a waiting list on clinical outcomes in opiate addicts awaiting outpatient treatment: Executive summary. 2004a, in collaboration with clinical colleagues Morris, M., Forrest, S., Craven, R. & McCrossan, H.
  • Strang J, Best D, Ridge G, Gossop M, Farrell M. Randomised clinical trial of the effects of time on a waiting list on clinical outcomes in opiate addicts awaiting outpatient treatment. Final Report to the Department of Health. 2004b, in collaboration with clinical colleagues Morris, M., Forrest,S., Craven, R. & McCrossan, H., 84pp plus appendices
  • Strathdee G, Manning V, Best D, Keaney F, Bhui K, Witton J, et al. Dual diagnosis in a Primary Care Group (PCG) (100,000 population locality): A step by step epidemiological needs assessment and design of a training and service response model: Executive summary. 2002a
  • Strathdee G, Manning V, Best D, Keaney F, Bhui K, Witton J, et al. Dual diagnosis in a Primary Care Group (PCG) (100,000 population locality): A step by step epidemiological needs assessment and design of a training and service response model. Final Report to the Department of Health. 2002b, 94
  • UKADCU. Tackling drugs to build a better Britain: The government's 10-year strategy for tackling drug misuse. Cm 3945. HMSO, London 1998
  • UKCBTMM Project Group. The effectiveness and cost effectiveness of cognitive behavioural therapy for opiate misusers in methadone maintenance treatment: A multicentre, randomised, controlled trial. Final Report to the Department of Health. 2004, 81
  • Weaver T, Charles V, Madden P, Renton A. Co-morbidity of substance misuse and mental health problems: A study of the prevalence and management of co-morbidity among substance misuse and adult mental health treatment populations: Executive summary. 2002a
  • Weaver T, Charles V, Madden P, Renton A. Co-morbidity of substance misuse and mental health problems: A study of the prevalence and management of co-morbidity among substance misuse and adult mental health treatment populations. Report to the Department of Health. 2002b, 118

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.